Search Results 571-580 of 17292 for GLP-1 therapy
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.
... treatment works better than the current standard therapy. They also compare ... therapy, sulfonylureas, SGLT2 inhibitors, and GLP-1 agonists; Systemic ...
... one kidney split function less than 35% 11. Polycystic kidney disease. 12. Diabetes treated with SGLT2 inhibitor and/or GLP-1 agonist 13. Persistent ...
... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...
... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 ... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy ...
By condition, treatment or drug name. Search tips. Investigational Extended Wear Insulin Infusion Set During Home Use for Type 1 Diabetes. Print details. Share ...
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for ...
In the second part of the study, an expansion cohort of 14 patients will be treated at the recommended dose to confirm the tolerability of treatment and ...
... 1-2 prior lines of therapy. The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!